Home/Investors/Seventure Partners

Seventure Partners

Biotech Investor · 5 portfolio companies

Portfolio

5

Focus Areas

10

Top Stage

phase-1

Investment Focus

Gastroenterology Immunology Metabolic Disease Obesity Type 2 Diabetes Inflammatory Bowel Disease Oncology Orthopedics Dentistry Trauma

Portfolio Companies

Company	Stage	Valuation	Focus
Anto Biosciences	phase-1	—	Gastroenterology, Immunology
Cytoki Pharma	Phase 2	—	Metabolic Disease, Obesity
PEP-Therapy	Phase 1	—	Oncology
Graftys	Commercial	—	Orthopedics, Dentistry
CellVax	phase-2	—	Oncology

Frequent Co-Investors

Flagship Pioneering1 shared Johnson & Johnson Innovation1 shared Temasek Holdings1 shared Ysios Capital1 shared Lundbeckfonden BioCapital1 shared +ND Capital1 shared EDBI1 shared Italian Angels for Growth1 shared